Srinivasan G. , Seeler RA, Tiruvurny A., Spildes R.: Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol1982 ;59:250-252.
4.
Lane PA, Hathaway WE: Vitamin K in infancy. J Pediatr1985 ; 106:351-359.
5.
Comelissen M. , Steegers-Theunissen R., Kollee L., et al: Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol1993;168:923-928.
6.
Davies VA, Argent AC, Staub H., et al: Precursor prothrombin status in patients receiving anticonvulsant drugs. Lancet1985;1:126-128.
7.
Scott DA, Gholson CF, Netchvolodoff CV, et al: Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy. Am J Gastroenterol1991;86:500-502.
8.
Gidal B., Spencer N., Maly N., et al: Valproate-mediated disturbances of hemostasis. Neurology1994;44:1418-1422.
9.
Cheng RD, Kohrman MH, Kerr SL, et al: Thrombocytopenia associated with valproic acid that requires platelet transfusion. Ann Neurol1989;26:457-458.
10.
Delgado MR, Riela AR, Mills J., et al: Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol1994;9:311-314.
11.
Ganick DJ, Sunder T., Finley JL: Severe hematologic toxicity of valproic acid: A report of four patients . Am J Pediatr Hematol Oncol1990; 12:80-85.
12.
Kreuz W., Linde R., Funk M., et al: Valproate therapy induces von Willebrand disease type I. Epilepsia1992;33:178-184.
13.
Loiseau P.: Sodium valproate, platelet dysfunction, and bleeding. Epilepsia1981;22:141-146.
14.
Barr RD, Copeland SA, Stockwell ML, et al: Valproic acid and immune thrombocytopenia. Arch Dis Child1982;57:681-684.
15.
Voss H., Petrich C., Karch D., et al: Sodium valproate and platelet function. BMJ1976;2:179.
16.
Sandler RM, Emberson C., Roberts GE, et al: IgM platelet autoantibody due to sodium valproate. BMJ1978;2:1683-1684.
17.
Smith FR, Boots M.: Sodium valproate and bone marrow suppression. Ann Neurol1980;8:197-199.
18.
Mountain KR , Hirsh J., Gallus AS: Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet1970;1:265-268.
19.
Yerby MS: Risks of pregnancy in women with epilepsy. Epilepsia1992;33(Suppl 1):S23-S27.
20.
Cornelissen M., Steegers-Theunissen R., Kollee L., et al: Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol1993;168:884-888.
21.
Mandelbrot K., Guillamont M., Leclercq M., et al: Placental transfer of vitamin K1 and its implication in fetal hemostasis. Thromb Hemost1988;60:39-43.
22.
Hamulyak K. , Berg Agdb, Thijssen HHW, et al: The placental transport of [H 3]vitamin K1 in rats. Br J Haematol1987;65:335-338.
23.
Guillaumont MJ, Durr FM, Combet JM: Vitamin K1 diffusion across the placental barrier in the gravid female rat. Dev Pharmacol Ther1988; 11:57-64.
24.
Scott AK, Haynes BP, Schinkel KD, et al: Hepatic enzyme induction and vitamin K1 elimination in man. Eur J Clin Pharmacol1987;33:93-95.
25.
Bouwman CA, Seinen W., Koppe JG, Berg M.: Effects of 2,3,7,8-TCDD or 2,2',4,4',5,5'-HxCB on vitamin K-dependent blood coagulation factors in female germfree WAG/RIJ rats. Thromb Haemost1991;65:1221.
26.
Vermeer C.: γ-Carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase . Biochem J1990;266:625-636.
27.
Lipsky JJ: Mechanism of the inhibition of the γ-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics. Proc Natl Acad Sci U S A1984;81:2893-2897.
